Editorial
-
Back to the (BIO)Future!
Industry heads to BIO 2018 to learn about all the latest advances in bioprocessing technology.Tim Wright, Editor 05.08.18
-
President Trump + Biologics = A Win for Drugmakers?
Are biosimilars the latest victim in the drug pricing war?Tim Wright, Editor 04.10.18
-
Pharma Industry Growth Continues
Pharma market to be worth $1.06trn by 2022; contract service sector will grow to roughly $95bn.Tim Wright, Editor 01.29.18
-
Contract Packagers Talk Trends
Consolidation continues all across the contract services sectorTim Wright, Editor 11.07.17
-
Drug Delivery Innovation
Growth in biologics is driving advanced drug delivery technology solutionsTim Wright, Editor 10.11.17
-
Serialization
DSCSA Deadline Approaches
An expert panel will convene at Contract Pharma’s upcoming conference to discuss key serialization issues, challenges andTim Wright, Editor 09.06.17
-
Heading to BIO 2017!
Biotechs top people and newest technology innovations will be on hand in San Diego later this month.Tim Wright, Editor 06.06.17
-
The Results Are In!
The growing need for analytical testing and clinical trials services are driving outsourcing demand.Tim Wright, Editor 05.09.17
-
Trump Picks New FDA Commish
Combatting high drug prices and overregulation likely to be high on agendaTim Wright, Editor 04.03.17
-
Solid Dosage/Semi-solids
The Future of Oral Solids
The market for oral solids remains strong and continues to evolve through innovative drug delivery solutionsTim Wright, Editor 03.07.17
-
FDA Issues Final Guidance on Quality Agreements
Says the difference between the draft from May ’13 and the final guidance focuses on areas that needed to be clarifiedTim Wright, Editor 01.26.17
-
Collaboration is the Heart of Innovation
Mutually beneficial partnerships ultimately help to save patients’ livesTim Wright, Editor 11.09.16
-
That’s a Wrap!
The 15th Anniversary edition of Contract Pharma’s conference covered key industry trendsTim Wright, Editor 10.11.16
-
Rising to the Challenge
While preparing for the upcoming DSCSA requirements and beyond is a daunting task, it’s not one that is insurmountableTim Wright, Editor 09.08.16
-
The Top 25 Report
It’s time for Contract Pharma’s annual snapshot of the largest pharma & biopharma companies07.12.16
-
Biosimilars | Drug Development
Partnering for Success
Opportunity abounds for contract service providers in the robust biopharma marketTim Wright, Editor 06.02.16
-
Biosimilars
Biosimilars to the Rescue?
Will the new wave of “generic” biologics help curb soaring drug prices?Tim Wright, Editor 05.05.16
-
Drug Delivery | Drug Discovery | Injectables | Supply Chain
Covering Ground
From the negotiating table to the lab to the production line, we’ve got it coveredTim Wright, Editor 04.05.16
-
Drug Development
Is Pharma’s Future in Precision Medicine?
As the cost of drugs and healthcare continues to rise, industry stakeholders are looking to technological innovation for solutions. This has led to a trend towards the development of personalized, or precision, medicine, designed to provide tailored…Tim Wright, Editor 03.09.16
-
APIs | Biosimilars | Drug Development
APIs...Lifeblood of the Pharma Industry
The global active pharmaceutical ingredient (API) market is expected to reach the $200 billion mark by 2020 from where it stands today at about $150 billion. Forecast to grow at a healthy CAGR of 6.5%, according to a report published by MarketsandMar…Tim Wright, Editor 01.28.16
